Xiao Le
Chief Investment Officer at Wuxi Apptec, Inc.
Profile
Xiao Le is currently the Director of Corporate Development & Investment at Wuxi Apptec, Inc. and Vice President at 6 Dimensions Capital.
Previously, Mr. Le worked as a Director at Ambrx, Inc., an Independent Director at Ambrx Biopharma Cayman, Inc., and a Vice President at Frontline Bioventures.
Additionally, Mr. Le served as a Non-Executive Director at CANbridge Pharmaceuticals Inc. from 2020 to 2022.
Mr. Le received an undergraduate degree from The Johns Hopkins University and a graduate degree from MIT Sloan School of Management.
Xiao Le active positions
| Companies | Position | Start |
|---|---|---|
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Private Equity Investor | 2017-05-17 |
Wuxi Apptec, Inc.
 Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Chief Investment Officer | 2018-12-31 |
Former positions of Xiao Le
| Companies | Position | End |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Director/Board Member | 2022-07-04 |
| Frontline Bioventures | President | 2017-05-17 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director/Board Member | - |
| AMBRX INC | Director/Board Member | - |
Training of Xiao Le
| The Johns Hopkins University | Undergraduate Degree |
| MIT Sloan School of Management | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Private companies | 5 |
|---|---|
| Frontline Bioventures | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Finance |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
Wuxi Apptec, Inc.
Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Technology Services |
- Stock Market
- Insiders
- Xiao Le
